rWTC-MBTA Vaccine Induces Potent Adaptive Immune Responses Against Glioblastomas via Dynamic Activation of Dendritic Cells

. 2024 Apr ; 11 (14) : e2308280. [epub] 20240131

Jazyk angličtina Země Německo Médium print-electronic

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid38298111

Grantová podpora
Intramural Research Programs of the National Institutes of Health (NIH), including the National Cancer Institute (NCI) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Despite strides in immunotherapy, glioblastoma multiforme (GBM) remains challenging due to low inherent immunogenicity and suppressive tumor microenvironment. Converting "cold" GBMs to "hot" is crucial for immune activation and improved outcomes. This study comprehensively characterized a therapeutic vaccination strategy for preclinical GBM models. The vaccine consists of Mannan-BAM-anchored irradiated whole tumor cells, Toll-like receptor ligands [lipoteichoic acid (LTA), polyinosinic-polycytidylic acid (Poly (I:C)), and resiquimod (R-848)], and anti-CD40 agonistic antibody (rWTC-MBTA). Intracranial GBM models (GL261, SB28 cells) are used to evaluate the vaccine efficacy. A substantial number of vaccinated mice exhibited complete regression of GBM tumors in a T-cell-dependent manner, with no significant toxicity. Long-term tumor-specific immune memory is confirmed upon tumor rechallenge. In the vaccine-draining lymph nodes of the SB28 model, rWTC-MBTA vaccination triggered a major rise in conventional dendritic cell type 1 (cDC1) 12 h post-treatment, followed by an increase in conventional dendritic cell type 2 (cDC2), monocyte-derived dendritic cell (moDC), and plasmacytoid dendritic cell (pDC) on Day 5 and Day 13. Enhanced cytotoxicity of CD4+ and CD8+ T cells in vaccinated mice is verified in co-culture with tumor cells. Analyses of immunosuppressive signals (T-cell exhaustion, myeloid-derived suppressor cells (MDSC), M2 macrophages) in the GBM microenvironment suggest potential combinations with other immunotherapies for enhanced efficacy. In conclusion, the authors findings demonstrate that rWTC-MBTA induces potent and long-term adaptive immune responses against GBM.

Zobrazit více v PubMed

Stupp R., Mason W. P., Van Den Bent M. J., Weller M., Fisher B., Taphoorn M. J. B., Belanger K., Brandes A. A., Marosi C., Bogdahn U., Curschmann J., Janzer R. C., Ludwin S. K., Gorlia T., Allgeier A., Lacombe D., Cairncross J. G., Eisenhauer E., Mirimanoff R. O., N. Engl. J. Med. 2005, 352, 987. PubMed

Yaghi N. K., Gilbert M. R., Biomedicines 2022, 10, 427. PubMed

Zhao B., Zhao H., Zhao J., Ther Adv Med Oncol 2020, 12, 175883592093761.

Camacho L. H., Cancer Med. 2015, 4, 661. PubMed PMC

Yang T., Kong Z., Ma W., Hum Vaccin Immunother 2021, 17, 546. PubMed PMC

Maggs L., Cattaneo G., Dal A. E., Moghaddam A. S., Ferrone S., Front Neurosci 2021, 15, 662064. PubMed PMC

Sampson J. H., Gunn M. D., Fecci P. E., Ashley D. M., Nat. Rev. Cancer 2020, 20, 12. PubMed PMC

Lim M., Xia Y., Bettegowda C., Weller M., Nat. Rev. Clin. Oncol. 2018, 15, 422. PubMed

Tomaszewski W., Sanchez‐Perez L., Gajewski T. F., Sampson J. H., Clin. Cancer Res. 2019, 25, 4202. PubMed PMC

Lohr J., Ratliff T., Huppertz A., Ge Y., Dictus C., Ahmadi R., Grau S., Hiraoka N., Eckstein V., Ecker R. C., Korff T., Von Deimling A., Unterberg A., Beckhove P., Herold‐Mende C., Clin. Cancer Res. 2011, 17, 4296. PubMed

Antonarelli G., Corti C., Tarantino P., Ascione L., Cortes J., Romero P., Mittendorf E. A., Disis M. L., Curigliano G., Ann. Oncol. 2021, 32, 1537. PubMed PMC

Pérez‐Baños A., Gleisner M. A., Flores I., Pereda C., Navarrete M., Araya J. P., Navarro G., Quezada‐Monrás C., Tittarelli A., Salazar‐Onfray F., Br. J. Cancer 2023, 129, 572. PubMed PMC

Liau L. M., Ashkan K., Tran D. D., Campian J. L., Trusheim J. E., Cobbs C. S., Heth J. A., Salacz M., Taylor S., D'andre S. D., Iwamoto F. M., Dropcho E. J., Moshel Y. A., Walter K. A., Pillainayagam C. P., Aiken R., Chaudhary R., Goldlust S. A., Bota D. A., Duic P., Grewal J., Elinzano H., Toms S. A., Lillehei K. O., Mikkelsen T., Walbert T., Abram S. R., Brenner A. J., Brem S., Ewend M. G., et al., J. Transl. Med. 2018, 16, 142. PubMed PMC

Liau L. M., Ashkan K., Brem S., Campian J. L., Trusheim J. E., Iwamoto F. M., Tran D. D., Ansstas G., Cobbs C. S., Heth J. A., Salacz M. E., D'andre S., Aiken R. D., Moshel Y. A., Nam J. Y., Pillainayagam C. P., Wagner S. A., Walter K. A., Chaudhary R., Goldlust S. A., Lee I. Y., Bota D. A., Elinzano H., Grewal J., Lillehei K., Mikkelsen T., Walbert T., Abram S., Brenner A. J., Ewend M. G., et al., JAMA Oncol 2023, 9, 112. PubMed PMC

Schaller T. H., Sampson J. H., Expert Rev. Vaccines 2017, 16, 27. PubMed PMC

Eisenbarth S. C., Nat. Rev. Immunol. 2019, 19, 89. PubMed PMC

Satpathy A. T., Wu X., Albring J. C., Murphy K. M., Nat. Immunol. 2012, 13, 1145. PubMed PMC

Doebel T., Voisin B., Nagao K., Trends Immunol. 2017, 38, 817. PubMed

Cabeza‐Cabrerizo M., Cardoso A., Minutti C. M., Pereira da Costa M., Reis e Sousa C., Dendritic Cells Revisited. Annu Rev Immunol 2021, 39, 166. PubMed

Bowman‐Kirigin J. A., Desai R., Saunders B. T., Wang A. Z., Schaettler M. O., Liu C. J., Livingstone A. J., Kobayashi D. K., Durai V., Kretzer N. M., Cancer Immunol Res 2023, 11, 37. PubMed PMC

Medina R., Wang H., Caisova V., Cui J., Indig I. H., Uher O., Ye J., Nwankwo A., Sanchez V., Wu T., Adv. Ther. (Weinh) 2020, 3. PubMed PMC

Lechner M. G., Karimi S. S., Barry‐Holson K., Angell T. E., Murphy K. A., Church C. H., Ohlfest J. R., Hu P., Epstein A. L., J. Immunother. 2013, 36, 477. PubMed PMC

Ye J., Wang H., Medina R., Chakraborty S., Sun M., Valenzuela A., Sang X., Zhang Y., Uher O., Zenka J., Pacak K., Zhuang Z., J. Exp. Clin. Cancer Res. 2023, 42, 163. PubMed PMC

Sharma P., Aaroe A., Liang J., Puduvalli V. K., Neurooncol Adv. 2023, 5, vdad009. PubMed PMC

Watowich M. B., Gilbert M. R., Larion M., Trends Cancer 2023, 9, 270. PubMed PMC

Hatano M., Kuwashima N., Tatsumi T., Dusak J. E., Nishimura F., Reilly K. M., Storkus W. J., Okada H., J. Transl. Med. 2004, 2, 40. PubMed PMC

Belmans J., Van Woensel M., Creyns B., Dejaegher J., Bullens D. M., Van Gool S. W., Sci. Rep. 2017, 7, 13902. PubMed PMC

Johanns T. M., Ward J. P., Miller C. A., Wilson C., Kobayashi D. K., Bender D., Fu Y., Alexandrov A., Mardis E. R., Artyomov M. N., Schreiber R. D., Dunn G. P., Cancer Immunol. Res. 2016, 4, 1007. PubMed PMC

Genoud V., Marinari E., Nikolaev S. I., Castle J. C., Bukur V., Dietrich P.‐Y., Okada H., Walker P. R., Oncoimmunology 2018, 7, e1501137. PubMed PMC

Wouters R., Bevers S., Riva M., De Smet F., Coosemans A., Cancers (Basel) 2020, 13, 19. PubMed PMC

Luksik A. S., Yazigi E., Shah P., Jackson C. M., Cancers (Basel) 2023, 15. PubMed PMC

Sheng K.‐C., Pouniotis D. S., Wright M. D., Tang C. K., Lazoura E., Pietersz G. A., Apostolopoulos V., Immunology 2006, 118, 372. PubMed PMC

Longhi M. P., Trumpfheller C., Idoyaga J., Caskey M., Matos I., Kluger C., Salazar A. M., Colonna M., Steinman R. M., J. Exp. Med. 2009, 206, 1589. PubMed PMC

Gladue R. P., Paradis T., Cole S. H., Donovan C., Nelson R., Alpert R., Gardner J., Natoli E., Elliott E., Shepard R., Bedian V., Cancer Immunol. Immunother. 2011, 60, 1009. PubMed PMC

Edwards A. D., Diebold S. S., Slack E. M. C., Tomizawa H., Hemmi H., Kaisho T., Akira S., Sousa C. R. E., Eur. J. Immunol. 2003, 33, 827. PubMed

Schulz O., Diebold S. S., Chen M., Näslund T. I., Nolte M. A., Alexopoulou L., Azuma Y.‐T., Flavell R. A., Liljeström P., Reis E Sousa C., Nature 2005, 433, 887. PubMed

Wang X., Wu K., Keeler S. P., Mao D., Agapov E. V., Zhang Y., Holtzman M. J., J. Immunol. 2021, 206, 1297. PubMed PMC

Schreibelt G., Tel J., Sliepen K. H. E. W. J., Benitez‐Ribas D., Figdor C. G., Adema G. J., De Vries I. J. M., Cancer Immunol. Immunother. 2010, 59, 1573. PubMed PMC

Antonios J. P., Soto H., Everson R. G., Moughon D., Orpilla J. R., Shin N. P., Sedighim S., Treger J., Odesa S., Tucker A., Neuro Oncol 2017, 19, 796. PubMed PMC

Medina R., Wang H., Caisová V., Cui J., Indig I. H., Uher O., Ye J., Nwankwo A., Sanchez V., Wu T., Advanced Therapeutics 2020, 3. PubMed PMC

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...